Qatar Airways Cargo and DHL Global Forwarding have transported 246 containers of active pharma shipments from Milan, Italy to Chicago, USA between October and December 2020. The containers were transported by temperature-controlled trucks to Indianapolis from Chicago. These pharma shipments are being moved using RAP active containers leased from both DokaSch and Envirotainer. The pharma shipments consist of insulin, an injectable prescription medicine for adults with type 2 diabetes used to improve blood sugar (glucose) and reduce the risk of major cardiovascular events in people who have heart diseases or multiple cardiovascular risk factors.
Guillaume Halleux, Chief Officer Cargo said, Qatar Airways, “We are glad to support DHL Global Forwarding with this large movement of injectable prescription medicines that will benefit adults with type 2 diabetes. The logistics around pharmaceutical transportation is complex and being at the forefront of time and temperature-sensitive transportation, we understand the intricacies of a seamless cool chain. Our QR Pharma solution is designed keeping in mind the seamless transport of all kinds of pharmaceuticals and healthcare products.”
Christian Giacomin, Head of Airfreight Product Capacity Management & Pricing, DHL Global Forwarding (Italy) Spa said, “This important cooperation with Qatar Airways Cargo is a further step that adds value to our comprehensive portfolio of transportation solutions for the pharmaceutical products, enforcing our long-lasting expertise in this sector.”
To be able to support its customer and the end user of the product, the airline implemented an additional weekly frequency directly from Milan to Chicago, bringing the total number of B777 freighters from Milan to Chicago to three per week.
The significant investments in cold chain management are part of the cargo carrier’s strategy and commitment to improving and enhancing its product offering and also support the logistics around the global Covid-19 vaccination endeavour.